KalVista Pharmaceuticals, Inc. (KALV) Insider Traders

$11.85

north_east
$0.1 (0.85%)
Day's range
$11.6
Day's range
$11.93

KalVista Pharmaceuticals, Inc. Insider Transactions

KalVista Pharmaceuticals, Inc. Insider Trades History

Insider Name Buy/Sell Shares Bought/Sold
@ Price
Total Transaction Shares Held
After Transaction
Transaction Date Filing Date Details
Audhya Paul K.

CHIEF MEDICAL OFFICER

Sell 8,077 @ $9.26 $74.77 K 94,199 11/18/2024 11/19/2024
Palleiko Benjamin L

Director, CHIEF EXECUTIVE OFFICER

Sell 7,352 @ $12.19 $89.62 K 250,800 09/09/2024 09/10/2024
Audhya Paul K.

CHIEF MEDICAL OFFICER

Sell 2,135 @ $12.40 $26.47 K 83,745 08/23/2024 08/26/2024
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Sell 1,916 @ $12.40 $23.76 K 85,676 08/23/2024 08/26/2024
Audhya Paul K.

CHIEF MEDICAL OFFICER

Sell 7,973 @ $12.01 $95.78 K 80,880 08/19/2024 08/21/2024
Palleiko Benjamin L

Director, CHIEF EXECUTIVE OFFICER

Sell 14,215 @ $12.01 $170.77 K 242,527 08/19/2024 08/21/2024
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Sell 7,102 @ $12.01 $85.32 K 84,467 08/19/2024 08/21/2024
Palleiko Benjamin L

Director, CHIEF EXECUTIVE OFFICER

Sell 7,465 @ $11.53 $86.07 K 224,547 06/07/2024 06/10/2024
Feener Edward P.

CHIEF SCIENTIFIC OFFICER

Sell 8,088 @ $11.76 $95.15 K 72,858 05/20/2024 05/21/2024
Showing 21 to 29 of 29 results
Page 2 of 2

KalVista Pharmaceuticals, Inc. FAQ's

The list of insiders at KalVista Pharmaceuticals, Inc. includes Palleiko Benjamin L, Venrock Healthcare Capital Partners III, L.P., Yea Christopher, Audhya Paul K..

Insiders have sold a total of 29.44 K KalVista Pharmaceuticals, Inc. shares in the last 12 months for a total of 303.79 K sold.

The following insiders have sold KalVista Pharmaceuticals, Inc. shares in the last 12 months: Palleiko Benjamin L ($204.33 K), Yea Christopher ($44.77 K), Audhya Paul K. ($54.69 K),

Insiders have purchased a total of 361.21 K KalVista Pharmaceuticals, Inc. shares in the last 12 months for a total of 3.32 M.

The following insiders have purchased KalVista Pharmaceuticals, Inc. shares in the last 12 months: Venrock Healthcare Capital Partners III, L.P. ($3.32 M),